T 0025/10 (PPAR Ligands for insulin resistant hypertension/BETHESDA) of 16.02.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T002510.20110216
- Date of decision
- 16 February 2011
- Case number
- T 0025/10
- Petition for review of
- -
- Application number
- 07007054.5
- IPC class
- A61K 31/41
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
- Applicant name
- Bethesda Pharmaceuticals, Inc.
- Opponent name
- -
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 53(c)European Patent Convention Art 76(1)
- Keywords
- Main request, auxiliary requests 5: subject-matter of divisional extents earlier application; not directly and unambiguously derivable
Auxiliary requests 1 to 4, 6 and 7; 'Therapy consisting of pharmaceutical substances for use in treatment' not allowable under Art. 53(c) EPC. - Catchword
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.